Back
Rocket Pharmaceuticals, Inc. Vs. Builders FirstSource, Inc. Industry Stock Comparison
Sell
37
RCKT
Rocket Pharmaceuticals, Inc.
Last Price:
$3.73
Seasonality Move:
-13.93%
Buy
67
BLDR
Builders FirstSource, Inc.
Last Price:
$124.75
Seasonality Move:
14.1%
Sell
37
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Is Rocket Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.73. The Score for RCKT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
RCKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Builders FirstSource, Inc. (BLDR)
is a Buy
Is Builders FirstSource, Inc. a Buy, Sell or Hold?
-
The current Builders FirstSource, Inc. [BLDR] share price is $124.66. The Score for BLDR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
BLDR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals, Inc.'s stock price today?
-
The Rocket Pharmaceuticals, Inc. share price today is $3.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
BLDR Stock Price Chart
What is Builders FirstSource, Inc.'s stock price today?
-
The Builders FirstSource, Inc. share price today is $124.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLDR is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | -1266237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.32 - 3.64) | Buy |
| Bollinger Bands (100): | (3.09 - 3.69) | Buy |
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.27 | Buy |
| Relative Strength Index (14 RSI): | 70.25 | Buy |
| Chaikin Money Flow: | 3995063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.39 - 112.11) | Buy |
| Bollinger Bands (100): | (105.29 - 133.21) | Buy |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.63 | Buy |
| 20-day SMA: | 3.5 | Buy |
| 50-day SMA: | 3.37 | Buy |
| 200-day SMA: | 3.96 | Sell |
| 8-day EMA: | 3.59 | Buy |
| 20-day EMA: | 2.79 | Buy |
| 50-day EMA: | 1.6 | Buy |
| 200-day EMA: | 0.49 | Buy |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.78 | Buy |
| 20-day SMA: | 106.66 | Buy |
| 50-day SMA: | 107.46 | Buy |
| 200-day SMA: | 120.17 | Buy |
| 8-day EMA: | 111.03 | Buy |
| 20-day EMA: | 108.19 | Buy |
| 50-day EMA: | 110.09 | Buy |
| 200-day EMA: | 123.34 | Buy |
Rocket Pharmaceuticals, Inc. Earnings Growth & RCKT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.12 per share.
Builders FirstSource, Inc. Earnings Growth & BLDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $2.05 per share.
Rocket Pharmaceuticals, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Builders FirstSource, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||